Perpetual Ltd purchased a new position in Nutanix, Inc. (NASDAQ:NTNX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,500 shares of the technology company’s stock, valued at approximately $520,000.
Several other institutional investors and hedge funds have also recently modified their holdings of NTNX. Freedom Investment Management Inc. grew its stake in Nutanix by 4.0% during the third quarter. Freedom Investment Management Inc. now owns 3,883 shares of the technology company’s stock valued at $230,000 after acquiring an additional 151 shares in the last quarter. CIBC Asset Management Inc grew its position in shares of Nutanix by 3.4% during the third quarter. CIBC Asset Management Inc now owns 7,036 shares of the technology company’s stock valued at $417,000 after purchasing an additional 233 shares in the last quarter. Paragon Capital Management Inc. increased its holdings in shares of Nutanix by 1.0% in the third quarter. Paragon Capital Management Inc. now owns 26,082 shares of the technology company’s stock worth $1,545,000 after purchasing an additional 258 shares during the last quarter. Larson Financial Group LLC lifted its position in shares of Nutanix by 122.7% in the third quarter. Larson Financial Group LLC now owns 510 shares of the technology company’s stock worth $30,000 after buying an additional 281 shares in the last quarter. Finally, Advisors Asset Management Inc. boosted its stake in Nutanix by 150.7% during the third quarter. Advisors Asset Management Inc. now owns 534 shares of the technology company’s stock valued at $32,000 after buying an additional 321 shares during the last quarter. Institutional investors own 85.25% of the company’s stock.
Insider Activity at Nutanix
In other Nutanix news, CEO Rajiv Ramaswami sold 63,901 shares of the company’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $65.85, for a total value of $4,207,880.85. Following the completion of the sale, the chief executive officer now directly owns 649,034 shares in the company, valued at approximately $42,738,888.90. This represents a 8.96 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Virginia Gambale sold 6,060 shares of the stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $64.73, for a total value of $392,263.80. Following the transaction, the director now directly owns 45,330 shares in the company, valued at $2,934,210.90. The trade was a 11.79 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 82,065 shares of company stock worth $5,405,141. Company insiders own 6.80% of the company’s stock.
Wall Street Analyst Weigh In
View Our Latest Analysis on Nutanix
Nutanix Price Performance
Shares of NTNX stock opened at $66.44 on Thursday. The company has a market capitalization of $17.80 billion, a P/E ratio of -189.83, a P/E/G ratio of 10.66 and a beta of 1.16. The company’s 50-day simple moving average is $65.84 and its two-hundred day simple moving average is $60.62. Nutanix, Inc. has a one year low of $43.35 and a one year high of $75.80.
About Nutanix
Nutanix, Inc engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers’ enterprise infrastructure.
Featured Stories
- Five stocks we like better than Nutanix
- How Can Investors Benefit From After-Hours Trading
- Oracle Announces Game-Changing News for the AI Industry
- Overbought Stocks Explained: Should You Trade Them?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- The Most Important Warren Buffett Stock for Investors: His Own
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Nutanix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutanix and related companies with MarketBeat.com's FREE daily email newsletter.